IVZ vs PCRX · rev $3.57B vs P/E 174, rev $369.8M
Invesco Plc (IVZ) versus Pacira BioSciences, Inc. (PCRX) — a side-by-side from cached financials, not a winner call.
Invesco Plc (IVZ) is a asset management company listed on NYSE.
Pacira BioSciences, Inc. (PCRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported IVZ revenue for 2026-06-30 was $3.57B. Net income was $558.0M. IVZ currently screens at market cap $12.76B.
Latest reported PCRX revenue for 2026-06-30 was $369.8M. Net income was $7.6M. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.
IVZ currently screens at market cap $12.76B. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.
Not investment advice. Open the IVZ and PCRX stock pages for the full models.
Not investment advice.